Article
U.S. FDA staff raises concerns on Spectrum Pharma's cancer drug
Rating:
0.0
Views:
176
Likes:
1
Library:
1
The U.S. Food and Drug Administration's (FDA) staff on Tuesday raised concerns over the safety of Spectrum Pharmaceutical's experimental cancer drug and questioned the benefits it provided over existing therapies, dragging its shares 30%.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value